Abbott (NYSE: ABT) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $10.24 billion versus the consensus estimate of $10.17 billion.

GUIDANCE:

Abbott sees FY2024 EPS of $4.50-$4.70, versus the consensus of $4.63.

For earnings history and earnings-related data on Abbott (ABT) click here.